Mr Watkins is a Chartered Accountant and member of the Governance Institute of Australia with extensive ASX experience across biotechnology, bioscience, resources, and information technology sectors.

He specialises in ASX statutory reporting, compliance, corporate governance, and board and secretarial support.

Mr Watkins serves as Company Secretary for several ASX-listed entities and is currently the SEA Regional Practice Lead & Australia Market Lead at Vistra (Australia) Pty Ltd, a global corporate services provider supporting clients in the Fund, Corporate, Capital Markets, and Private Wealth sectors.

Memphasys Limited (ASX: MEM) is an Australian-based reproductive biotechnology company commercialising the Felix™ System, a patented bio separation technology that isolates the most viable sperm cells for human assisted reproduction.

For investor and media enquiries:
David Tasker, Chapter One Advisors
E: dtasker@chapteroneadvisors.com.au
M: +61 433 112 936

Find

Level 1, 34-36 Richmond Road,
Homebush West, NSW 2140
Australia

Call

Privacy Preference Center